Skip to Content

Tag: Sleep Therapy


ResMed: ‘Our third-quarter results reflect strong performance’

April 28, 2022HME News Staff

SAN DIEGO – ResMed reported revenue increased 12% to $864.5 million in its third quarter fiscal year 2022. The company reported revenue, excluding software-as-a-service, increased 18% in the United States, Canada and Latin America, primarily due to a recall by one of its competitors and a recovery of core sleep patient flow that has been impacted by the COVID-19 pandemic. “Our third-quarter results reflect strong performance across our business, resulting in double-digit top-line...

CPAP Devices, CPAP recall, Financial Results, ResMed, Sleep Therapy

Read Full Articlered right arrow icon


Philips: Sales were down, orders were up in Q4, 2021

January 24, 2022HME News Staff

AMSTERDAM, the Netherlands – Philips’ comparable sales decreased 32% in the fourth quarter of 2021 for the Connected Care business due, in part, to a double-digit decline in Sleep & Respiratory Care associated with the recall.  For the full year, the Connected Care business recorded a 23% comparable sales decrease.  “Patient well-being is at the heart of everything we do at Philips, and we remain extremely focused on repairing and replacing the devices related to...

Philips earnings, Philips Recall, Respiratory Therapy, Sleep Therapy

Read Full Articlered right arrow icon

Also Noted

AppYea invests in sleep monitor

January 3, 2022HME News Staff

FORT WORTH, Texas – AppYea has acquired SleepX and its flagship product DreamIT, a wearable monitoring solution to treat sleep apnea and snoring. Post-merger, the two companies will focus on the further development and commercialization of SleepX’s solution, including investments in R&D and sales and marketing, as well as an upcoming calibration trial. “I am delighted that we have completed the acquisition of SleepX,” said Boris (Bary) Molchadsky, AppYea’s chairman....

monitoring solution, Sleep Therapy, wearable

Read Full Articlered right arrow icon

Also Noted

Bleep attracts funding 

December 13, 2021HME News Staff

MADISON, Wis. – Bleep has been awarded a $1.7 million SBIR grant from the National Institutes of Health to optimize positive airway pressure mask design for use in the home and acute care/hospital settings. The company will use the grant to optimize its Eclipse PAP, which focuses on having no headgear or straps and addressing leaks, and produce the validation data necessary for successful market commercialization. “Eclipse, our generation two product, will not only continue to address...

Bleep, CPAP Mask, Sleep Therapy

Read Full Articlered right arrow icon

Lewis Gradon


F&P reports flat home care revenue

November 29, 2021HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported total operating revenue of $900 million for the first six months ended Sept. 30, 2021, a 1% decrease compared to the same period the previous financial year.  Net profit after tax was $222 million, a 2% decrease.  “For nearly two years now, our customers have been working selflessly to care for patients during a pandemic,” said Lewis Gradon, managing director and CEO. “Our people and suppliers have...

CPAP, Financial Results, Fisher & Paykel Healthcare, Sleep Therapy

Read Full Articlered right arrow icon


ResMed sees boost from demand, recall

October 29, 2021HME News Staff

SAN DIEGO – ResMed reported revenue of $904 million for the first quarter of its fiscal year 2022, a 20% increase compared to the prior year period.  Net income was $203.6 million, a 14% increase.  “Our first-quarter results demonstrate strong performance across our business with double-digit growth in both top-line and bottom-line metrics, driven by ongoing high demand for our sleep and respiratory care products, and steady growth across our software-as-a-service business,”...

CPAP, Financial Results, ResMed, Sleep Therapy

Read Full Articlered right arrow icon

Also Noted

Oventus reapplies to PDAC

October 26, 2021HME News Staff

BRISBANE, Australia – Oventus Medical has reapplied to Palmetto GBA, the pricing data analysis and coding contractor (PDAC), for approval of the newly submitted Optima version of its O2Vent oral appliance to treat obstructive sleep apnea. This version of the device is designed specifically for Medicare patients. “In the meantime, this means that O2Vent Optima will not be able to be supplied to Medicare patients in its own right for reimbursement purposes,” the company stated....

O2Vent, Oral appliance therapy, Oventus Medical, Sleep Apnea, Sleep Therapy

Read Full Articlered right arrow icon

Also Noted

Oventus Medical reports growth

August 31, 2021HME News Staff

BRISBANE, Australia – Oventus Medical booked revenues of $1.1 million for the 12 months ended June 30, an increase of 160% over the prior period. “FY21 was Oventus’ best year for device sales on record, despite what remained a highly challenging patient treatment environment for in-person clinical settings, which were heavily tampered by the COVID-19 pandemic,” the company stated. Contributing to Oventus’s growth in the year: lab-in-lab sites that remained operational...

CPAP Alternative, O2 vent, Oventus Medical, Sleep Therapy

Read Full Articlered right arrow icon

Seema Khosla

Specialty Providers

Sleep app puts ‘patients at the center’

August 27, 2021Tracy Orzel

DARIEN, Ill. – A proposed web-based app called “MySleepVillage” took second place in the American Academy of Sleep Medicine’s first ever Change Agents, a contest designed to generate creative ideas for diagnosing and treating obstructive sleep apnea.  The app aims to streamline patient communication and testing; connect to physicians, insurers and medical equipment companies; and provide options for remote monitoring of CPAP usage. The team behind it estimates that...

AASM, American Academy of Sleep Medicine, Obstructive Sleep Apnea, Sleep Therapy

Read Full Articlered right arrow icon

Business Development

Virtual visits expected to continue for sleep

May 28, 2021John Andrews

As the country prepares to transition away from COVID-related restrictions, the sleep therapy industry is looking at how to proceed with patient care, CPAP provision and sleep testing going forward. One of the main issues is whether continuing with virtual technology applications used during the height of the pandemic is beneficial or necessary. According to some sleep specialists, the trend will continue. Katherine Royster, vice president for sales and marketing at Winter Haven, Fla.-based 3B...

3B Medical, CPAP, Phillips, rtNow, Sleep Therapy

Read Full Articlered right arrow icon